Loading patent…
AssigneeNMI Naturwissenschaftliches und Medizinisches Institut an der Universitaet Tuebingen
InventorsJuergen Mollenhauer, Burkhard Schlosshauer, Beate Scholz
Estimating the term…
The present invention relates to a method for inhibiting and/or preventing angiogenesis, the method comprising the step of administering a biocompatible composition, which is polymerizable to a hydrogel-forming material and which is based on a hydrophilic polymer, for inhibiting and/or preventing angiogenesis or endothelial cell proliferation, wherein the hydrophilic polymer is crosslinkable serum albumin or crosslinkable serum protein, in a subject in need of being treated. The invention furthermore relates to a method for inhibiting and/or preventing angiogenesis or endothelial cell proliferation in a subject in need thereof, comprising the step of administering a polymerized hydrogel-material, which has been obtained by polymerizing a serum-albumin- or serum-protein-based composition.
A method for inhibiting and/or preventing angiogenesis or endothelial cell proliferation, comprising the step of administering to a subject in need thereof a biocompatible composition, which composition is polymerizable to a hydrogel-material and which is based on a hydrophilic polymer, wherein the hydrophilic polymer is crosslinkable serum albumin or crosslinkable serum protein.
A method for inhibiting and/or preventing angiogenesis or endothelial cell proliferation in a subject in need thereof, comprising the step of administering a polymerized hydrogel-material, which has been obtained by polymerizing a serum-albumin- or serum-protein-based composition.
Dependencies are inferred from the claim text.